Bard Associates’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-76,615
| Closed | -$488K | – | 167 |
|
2019
Q2 | $488K | Sell |
76,615
-500
| -0.6% | -$3.19K | 0.24% | 105 |
|
2019
Q1 | $448K | Sell |
77,115
-1,000
| -1% | -$5.81K | 0.23% | 110 |
|
2018
Q4 | $492K | Sell |
78,115
-1,000
| -1% | -$6.3K | 0.28% | 102 |
|
2018
Q3 | $452K | Sell |
79,115
-500
| -0.6% | -$2.86K | 0.21% | 118 |
|
2018
Q2 | $488K | Sell |
79,615
-3,600
| -4% | -$22.1K | 0.23% | 116 |
|
2018
Q1 | $556K | Sell |
83,215
-3,800
| -4% | -$25.4K | 0.28% | 106 |
|
2017
Q4 | $646K | Sell |
87,015
-1,300
| -1% | -$9.65K | 0.31% | 105 |
|
2017
Q3 | $624K | Sell |
88,315
-200
| -0.2% | -$1.41K | 0.29% | 105 |
|
2017
Q2 | $620K | Sell |
88,515
-50
| -0.1% | -$350 | 0.28% | 107 |
|
2017
Q1 | $615K | Sell |
88,565
-3,950
| -4% | -$27.4K | 0.29% | 108 |
|
2016
Q4 | $509K | Sell |
92,515
-1,500
| -2% | -$8.25K | 0.24% | 107 |
|
2016
Q3 | $471K | Sell |
94,015
-300
| -0.3% | -$1.5K | 0.23% | 110 |
|
2016
Q2 | $424K | Buy |
94,315
+340
| +0.4% | +$1.53K | 0.22% | 115 |
|
2016
Q1 | $422K | Buy |
93,975
+15,350
| +20% | +$68.9K | 0.24% | 114 |
|
2015
Q4 | $414K | Sell |
78,625
-2,465
| -3% | -$13K | 0.24% | 108 |
|
2015
Q3 | $468K | Sell |
81,090
-1,400
| -2% | -$8.08K | 0.27% | 103 |
|
2015
Q2 | $590K | Sell |
82,490
-4,450
| -5% | -$31.8K | 0.29% | 97 |
|
2015
Q1 | $579K | Sell |
86,940
-1,800
| -2% | -$12K | 0.28% | 104 |
|
2014
Q4 | $531K | Sell |
88,740
-600
| -0.7% | -$3.59K | 0.25% | 113 |
|
2014
Q3 | $441K | Sell |
89,340
-75
| -0.1% | -$370 | 0.21% | 121 |
|
2014
Q2 | $402K | Sell |
89,415
-1,900
| -2% | -$8.54K | 0.16% | 144 |
|
2014
Q1 | $411K | Buy |
91,315
+1,362
| +2% | +$6.13K | 0.17% | 138 |
|
2013
Q4 | $460K | Sell |
89,953
-1,350
| -1% | -$6.9K | 0.19% | 133 |
|
2013
Q3 | $414K | Sell |
91,303
-1,537
| -2% | -$6.97K | 0.18% | 138 |
|
2013
Q2 | $474K | Buy |
+92,840
| New | +$474K | 0.22% | 129 |
|